| abstract |
The present invention relates to solid pharmaceutical compositions containing compound 4- (trifluoromethyl) -5- (2,6-dimorpholinopyrimidin-4-yl) pyridine-2-amine - phosphatidylinositol-3-kinase inhibitor, or a pharmaceutically acceptable salt thereof, stearyl fumarate and optionally at least one additional pharmaceutically acceptable carrier. The present invention also relates to methods for their preparation and use as medicaments for cancer treatment. |